Company Ticker News August 25, 2021Bristol Myers' (BMY) sBLA for Orencia Gets FDA Priority Review 0 0 Share
Press Release August 20, 2021U.S. Food and Drug Administration Approves Opdivo® (nivolumab) for the Adjuvant Treatment of Patients with High-Risk Urothelial Carcinoma 1 0 Share
Press Release August 20, 2021Europe Approves Bristol Myers' BCMA-Targeted Multiple Myeloma Immunotherapy 0 0 Share
Press Release August 19, 2021Bristol Myers Squibb Receives European Commission Approval for Abecma (Idecabtagene Vicleucel), the First Anti-BCMA CAR T Cell Therapy for Relapsed and Refractory Multiple Myeloma 0 0 Share
Company Ticker News August 17, 2021Got $100? Here Are 3 Top Dividend Growth Stocks to Jump-Start Your Portfolio 0 0 Share
Company Ticker News August 7, 20214 Perfect Dividend Stocks That'll Help You Crush Inflation 0 0 Share
